Trulicity and Ozempic are not the same medication, but they belong to the same drug class and work in a similar way. Both are once-weekly injectable GLP-1 receptor agonists prescribed for type 2 diabetes, and both mimic a gut hormone that helps regulate blood sugar and appetite. The key differences lie in their active ingredients, how effectively they lower blood sugar and body weight, and their specific FDA-approved uses.
How They Work
Trulicity contains dulaglutide, made by Eli Lilly. Ozempic contains semaglutide, made by Novo Nordisk. Both drugs copy the action of a natural hormone called GLP-1, which your body releases after eating. This hormone signals your pancreas to produce more insulin, slows down digestion so food leaves your stomach more gradually, and reduces appetite by acting on hunger signals in the brain.
Although the basic mechanism is the same, the two drugs have different molecular structures. Those structural differences translate into meaningful gaps in clinical performance, particularly when it comes to blood sugar control and weight loss.
Blood Sugar Control: Head-to-Head Results
The clearest comparison comes from the SUSTAIN 7 trial, published in The Lancet Diabetes & Endocrinology, which directly tested Ozempic against Trulicity in people with type 2 diabetes over 40 weeks. Ozempic produced significantly larger reductions in HbA1c (a measure of average blood sugar over roughly three months) at every dose pairing.
At the lower doses, Ozempic 0.5 mg reduced HbA1c by 1.5 percentage points compared to 1.1 points with Trulicity 0.75 mg. At the higher doses, Ozempic 1.0 mg reduced HbA1c by 1.8 points versus 1.4 points with Trulicity 1.5 mg. Both differences were statistically significant, meaning they weren’t due to chance.
Weight Loss Differences
The same trial showed a clear weight loss advantage for Ozempic. People taking Ozempic 0.5 mg lost an average of 4.6 kg (about 10 pounds), while those on Trulicity 0.75 mg lost 2.3 kg (about 5 pounds). At the higher doses, Ozempic 1.0 mg produced 6.5 kg of weight loss (roughly 14 pounds) compared to 3.0 kg (about 7 pounds) with Trulicity 1.5 mg.
At its maximum diabetes dose of 2.0 mg, Ozempic has shown average weight loss of about 6.3% of body weight, or around 14 pounds. Trulicity’s weight loss is more modest, typically in the range of 2 to 7 pounds depending on whether it’s used alone or alongside other diabetes medications. Neither drug is FDA-approved specifically for weight management, though semaglutide at a higher dose is sold under a separate brand name for that purpose.
FDA-Approved Uses
Both medications are approved to improve blood sugar in adults with type 2 diabetes, and both carry approvals to reduce the risk of major cardiovascular events like heart attack and stroke in people with type 2 diabetes and heart disease. But the details differ in important ways.
Trulicity is approved for children aged 10 and older with type 2 diabetes. Ozempic is only approved for adults. Trulicity’s cardiovascular approval also extends to adults who have multiple cardiovascular risk factors (such as smoking, high cholesterol, high blood pressure, or obesity), even without established heart disease. Ozempic’s cardiovascular indication is limited to adults who already have established cardiovascular disease.
Ozempic has one approval that Trulicity does not: it is FDA-approved to protect the kidneys in adults with type 2 diabetes and chronic kidney disease, slowing kidney damage, reducing the risk of kidney failure, and lowering the risk of cardiovascular death in that population.
Dosing Schedules
Both medications are injected once a week under the skin, but they use different dose ranges. Ozempic starts at 0.25 mg for the first four weeks as an initiation dose, then moves up to 0.5 mg, 1.0 mg, or a maximum of 2.0 mg. Trulicity starts at 0.75 mg and can be increased through 1.5 mg, 3.0 mg, and up to a maximum of 4.5 mg. The starting doses for both are meant to let your body adjust and aren’t expected to provide full blood sugar control on their own.
Side Effects
The most common side effects for both drugs involve the digestive system: nausea, vomiting, diarrhea, abdominal pain, and constipation. These symptoms tend to be worst during the dose escalation period and often improve as your body adjusts. In Ozempic’s clinical trials, about 3 to 4% of patients stopped taking the medication because of gastrointestinal side effects, compared to less than 1% of those on placebo. Higher doses of both drugs generally produce more GI symptoms.
Direct side-effect comparisons between the two drugs should be interpreted cautiously. Clinical trials use different patient populations and study designs, so reported rates don’t translate neatly from one drug’s trials to another’s. Neither medication should be used in people with type 1 diabetes or in patients with severe gastrointestinal conditions like gastroparesis.
Practical Differences
Both come as prefilled injection pens designed for weekly self-injection. Trulicity uses a single-dose pen with a hidden, pre-attached needle, so you never see or handle the needle yourself. Ozempic uses a multi-dose pen that requires you to attach a new needle tip before each injection and dial the correct dose.
Storage requirements are similar. Trulicity should be kept refrigerated between 36°F and 46°F but can stay at room temperature (below 86°F) for up to 14 days. If it’s been out of the fridge longer than that, it needs to be discarded. Neither drug should be frozen.
Choosing Between Them
If blood sugar reduction and weight loss are the top priorities, the head-to-head data favors Ozempic. If you need a medication approved for a child with type 2 diabetes, Trulicity is the only option of the two. If you have cardiovascular risk factors but haven’t yet had a heart attack or stroke, Trulicity’s broader cardiovascular indication may be relevant. And if you have chronic kidney disease alongside type 2 diabetes, Ozempic’s kidney protection approval sets it apart.
Cost, insurance coverage, and drug availability also play a significant role. Both are brand-name medications with no generic versions, and out-of-pocket pricing can vary substantially depending on your insurance plan. Your formulary may cover one but not the other, or require you to try one before switching.